Oruka Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -28 | -19 | -16 | |
EBITDA | -34,403 | -30,257 | -24,555 | -20,983 |
EBIT | -34,431 | -30,277 | -24,574 | -20,999 |
Net Income | -29,583 | -30,277 | -24,574 | -20,999 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,657 | -21,701 | -23,179 | -20,882 |
Cash | 46,935 | 91,253 | 65,396 | 83,572 |
Basic Shares | 54,420 | 44,067 | 42,233 | 41,679 |
Annual Financials
| Values in thousands | 2025-12-31 |
|---|---|
Revenue | $0 |
Gross Profit | -83 |
EBITDA | -121,968 |
EBIT | -122,051 |
Net Income | -105,433 |
Net Change In Cash | 0 |
Free Cash Flow | -88,419 |
Cash | 46,935 |
Basic Shares | 45,614 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.45 |
2025-09-30 | -$0.69 |
2025-06-30 | -$0.46 |
2025-03-31 | -$0.50 |